Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
EV/EBIT

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 21.6824.8716.1331.1828.05

What is the latest EV/EBIT ratio of GLAND PHARMA ?

The latest EV/EBIT ratio of GLAND PHARMA is 21.68 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202521.68
Mar202424.87
Mar202316.13
Mar202231.18
Mar202128.05

How is EV/EBIT of GLAND PHARMA Trending?

Years EV/EBIT % Change
Mar2025 21.68
-12.83
Mar2024 24.87
54.18
Mar2023 16.13
-48.27
Mar2022 31.18
11.16
Mar2021 28.05 -

Other Financial Ratios of GLAND PHARMA


Compare EV/EBIT ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹29,491.8 Cr -2.4% -6.8% 3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,211.0 Cr 1.6% 6% -2% Stock Analytics
DIVIS LABORATORIES ₹171,898.0 Cr -0.7% -1.9% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,377.0 Cr -0.8% 7.4% 21.2% Stock Analytics
CIPLA ₹122,349.0 Cr -0.4% -3.4% 0.8% Stock Analytics
DR REDDYS LABORATORIES ₹103,789.0 Cr 1.2% 0.3% -1.5% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-2.4%

-6.8%

3%

SENSEX

1%

2.5%

6.5%


You may also like the below Video Courses